LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Healthcare & Medical Businesses for Sale
Childcare & Educational Businesses for Sale
Environmental Businesses for Sale
Construction & Landscaping Businesses for Sale
Wholesale & Distribution Businesses for Sale
Liquor Store Businesses for Sale
Transport & Shipping Businesses for Sale
Post Office Businesses for Sale
Restaurants for Sale
Convenience Stores & Lotto Businesses For Sale
Healthcare & Medical Franchise Opportunities
Child Care & Education Franchise Opportunities
Gift & Flower Shop Franchise Opportunities
Transport & Shipping Franchise Opportunities
Technology Franchise Opportunities
Smoke & Vape Shop Franchises for Sale
Hotel & Motel Franchises for Sale
Clothing & Shoe Store Franchise Opportunities
Travel Franchise Opportunities
Warehouse & Storage Franchise for Sale
Mixed Use Buildings for Sale or Rent
Plazas for Sale
Apartment Buildings for Sale
Industrial Buildings for Sale or Lease
Commercial Spaces for Sale or Lease
Industrial Units for Sale or Rent
Places of Worship for Sale
Retail Buildings for Sale or Lease
Office Buildings for Sale or Rent
Commercial Buildings for Sale or Lease
An email will be sent to registered email address.
Please select if you are: